Renowned fund manager Neil Woodford is urging the management of the unquoted positions he holds in his Woodford Patient Capital Trust (WPCT) to put themselves up for sale or list their businesses, as he bids to turn around his fund range performance.
A report in The Telegraph said Woodford had told Peter Hewitt, manager of the BMO Managed Portfolio Trust, which has a position in WPCT, that he had communicated to his positions "they needed to take action to demonstrate their value". One holding in the trust, Oxford Nanopore, could IPO "in the next year or two", said Hewitt while Spanish bank BBVA could look to purchase Atom Bank after having already taken a 40% stake. WPCT owns a 7.2% stake in Oxford Nanopore and almost 7% of Atom Bank. Woodford has faced much criticism recently due to underperformance in his range, with investo...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes